Arecoline in buccal cells reflects Areca nut dose
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Jennifer F Lai und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Hawaii Cancer Center, Honolulu, Hawaii, USA. Hauptthemen laut MEDLINE: Arecoline, Areca, Mouth Mucosa, Nuts. Die Arbeit nennt 20 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Areca nut (AN) is a carcinogen; its chewing cessation is, therefore, of worldwide interest. However, cessation biomarkers are lacking. We sought to establish arecoline in chewers' buccal cells (BCs) as a biomarker for AN dose. Self‐reported AN doses, expressed as the average AN load (“AANL”), the product of AN amount, chewing time, and chewing frequency, were correlated by regression analysis with chewers' BC arecoline, measured by liquid chromatography mass spectrometry. We then determined whether associations differed between Class 1 chewers (who consume AN alone or with slaked lime, leaf, and/or spices) and Class 2 chewers (who consume any combination of the aforementioned ingredients plus tobacco). Among the 103 chewers, 28 Class 1 and 39 Class 2 chewers had detectable arecoline levels, which were used for analyses. A linear regression of cube‐root transformed AANL on equally transformed BC arecoline levels provided the best model fit; resulting slopes and corresponding correlation coefficients were 0.86 and 0.40 ( p < 0.01) for all; 1.09 and 0.51 ( p < 0.01) for Class 1 chewers; 0.35 and 0.17 ( p = 0.29) for Class 2 chewers; and 0.94 and 0.45 ( p < 0.01), and 0.79 and 0.37 ( p = 0.08), respectively, for those who included or excluded lime. Relationships between AANL and BC arecoline levels were similar between chewers who included or excluded lime ( p = 0.76), but less between chewing classes ( p = 0.14). This provides confidence that BC arecoline can generally act as a reliable biomarker for AN dose, useful for estimating efficacy in AN cessation studies and population‐based chewing assessments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
- University of Guam, Mangilao, Guam, USA.
ORCID-Profile: Jennifer F Lai
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Lai, J. F., Mendez, A. J., Li, X., Wilkens, L. R., Herzog, T., & Franke, A. A. (2025). Arecoline in buccal cells reflects Areca nut dose. Drug Testing and Analysis. https://doi.org/10.1002/dta.3684
Vancouver
Lai JF, Mendez AJ, Li X, Wilkens LR, Herzog T, Franke AA. Arecoline in buccal cells reflects Areca nut dose. Drug Testing and Analysis. 2025. doi:10.1002/dta.3684
BibTeX
@article{Lai2025,
author = {Lai, Jennifer F and Mendez, Ana Joy and Li, Xingnan and Wilkens, Lynne R and Herzog, Thaddeus and Franke, Adrian A},
title = {Arecoline in buccal cells reflects Areca nut dose},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3684}
}
EUVIMED